Home

Sau fie Însoțitor de bord Emoţie robertsonnp cf.ac.uk Puternic barieră sarcom

Long-term outcome of paediatric-onset multiple sclerosis: a  population-based study
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study

Multiple sclerosis: early indicators of disease and assessing future risk
Multiple sclerosis: early indicators of disease and assessing future risk

Multiple Sclerosis and related disorders - MRC Centre for Neuropsychiatric  Genetics and Genomics - Cardiff University
Multiple Sclerosis and related disorders - MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University

PDF) Intravenous immunoglobulin for inflammatory demyelinating  polyneuropathy
PDF) Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy

NEIL P
NEIL P

Neil P Robertson's research works | Cardiff University, Cardiff (CU) and  other places
Neil P Robertson's research works | Cardiff University, Cardiff (CU) and other places

Non-covalent bridging of bithiophenes through chalcogen bonding grips - New  Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E
Non-covalent bridging of bithiophenes through chalcogen bonding grips - New Journal of Chemistry (RSC Publishing) DOI:10.1039/C9NJ06202E

NEURIMMINFL2016011098 1..6
NEURIMMINFL2016011098 1..6

B cell treatments for multiple sclerosis
B cell treatments for multiple sclerosis

PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients  with multiple sclerosis | Eleonora Cocco - Academia.edu
PDF) Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis | Eleonora Cocco - Academia.edu

Chronic traumatic encephalopathy: quantifying risk and clarifying  pathogenesis
Chronic traumatic encephalopathy: quantifying risk and clarifying pathogenesis

Postgraduate - Study - Cardiff University
Postgraduate - Study - Cardiff University

The economic burden of chronic neurological disease
The economic burden of chronic neurological disease

MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University
MRC Centre for Neuropsychiatric Genetics and Genomics - Cardiff University

LETTERS
LETTERS

Change in disability in patients with multiple sclerosis: a 20-year  prospective population-based analysis
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

Bilateral cerebellar ataxia as the sole manifestation of a unilateral  rostral pontine tegmental infarct Identification of amoeba
Bilateral cerebellar ataxia as the sole manifestation of a unilateral rostral pontine tegmental infarct Identification of amoeba

Professor Paul Morgan - People - Cardiff University
Professor Paul Morgan - People - Cardiff University

Survival and cause of death in multiple sclerosis: a prospective  population-based study
Survival and cause of death in multiple sclerosis: a prospective population-based study

This is an Open Access document downloaded from ORCA, Cardiff University's  institutional repository: https://orca.cardiff.ac.uk/
This is an Open Access document downloaded from ORCA, Cardiff University's institutional repository: https://orca.cardiff.ac.uk/

Physiotherapy and related activities in multiple sclerosis
Physiotherapy and related activities in multiple sclerosis

Neil P Robertson's research works | Cardiff University, Cardiff (CU) and  other places
Neil P Robertson's research works | Cardiff University, Cardiff (CU) and other places

Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of  Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML
Pharmaceuticals | Free Full-Text | B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders | HTML

Complement, a target for therapy in inflammatory and degenerative diseases  | Nature Reviews Drug Discovery
Complement, a target for therapy in inflammatory and degenerative diseases | Nature Reviews Drug Discovery

Treatments in Alzheimer's disease
Treatments in Alzheimer's disease

Immune reconstitution and treatment response in multiple sclerosis  following alemtuzumab
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab

Cerebrospinal Fluid Complement System Biomarkers in Demyelinating Disease.  Wioleta M. Zelek1, Dina Fathalla1, Angharad Morgan1,
Cerebrospinal Fluid Complement System Biomarkers in Demyelinating Disease. Wioleta M. Zelek1, Dina Fathalla1, Angharad Morgan1,